Carlsbad, CA, June 14, 2023 (GLOBE NEWSWIRE) — Palisade Bio (Nasdaq: PALI), a biopharmaceutical company advancing therapies for acute and chronic gastrointestinal (GI) complications, today announced that J.D. Finley, Chief Executive Officer of Palisade Bio will present at the Healthcare Virtual Conference Part II, presented by Maxim Group LLC and…Read More
Palisade Bio Participate in the Healthcare Virtual Conference Presented by Maxim Group LLC and Hosted by MVest
